S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
ACHC · Acadia Healthcare Company, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Acadia Healthcare Company Inc (ACHC)
NASDAQ NMS - GLOBAL MARKET
Health Care
$31.44
+0.04
(+0.13%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$31.44
$30.99
$32.06
52-WEEK RANGE
$31.44
$11.43
$35.83
What's happening
- ACHC is up 0.13% today, trading at $31.44. — Live quote
- Volume today (59,337) is well below its 3-month average of 2,282,800. (Finnhub fundamentals)
- Reports earnings on 2026-11-04 (after market close), 13 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.38 actual vs. $0.35 estimated (+7.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 9
Hold 6
Sell 1
Strong sell 0
Aggregate ratings for 2026-10-01 (20 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ACHC
+121.49%
vs S&P 500
+108.72%
1-YEAR RETURN
ACHC
+31.18%
vs S&P 500
+16.62%
6-MONTH RETURN
ACHC
+16.88%
3-MONTH RETURN
ACHC
-11.74%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.38
Est. $0.35
BEAT +7.4%
2026-04-26 (Q1 2026)
$0.37
Est. $0.27
BEAT +36.4%
2026-01-26 (Q4 2025)
$0.07
Est. $0.06
BEAT +18.2%
2025-10-26 (Q3 2025)
$0.72
Est. $0.68
BEAT +5.2%
Valuation Measures & Ratios
Enterprise Value4$5.18B
Forward P/E516.79
PEG Ratio6—
Price / Sales (TTM1)0.87
Price / Book71.37
EV4 / Revenue1.54
EV4 / EBITDA11.60
Profit Margin-33.44%
Operating Margin-28.18%
Return on Equity (ROE8)-50.02%
Return on Assets (ROA9)-19.56%
Avg Volume (3M)2,282,800
Quarterly history (5 periods)
| Measure | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.92B | — | $2.24B | $2.07B | $2.82B |
| P/E | -1.73 | — | 20.90 | 14.89 | 15.03 |
| Price/Book | 0.98 | — | 0.72 | 0.67 | 0.93 |
| ROE | -56.53% | — | 3.44% | 4.52% | 6.17% |
| ROA | -19.96% | — | 1.67% | 2.21% | 3.05% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short22,770,844
Change from Prior Settlement+5.86%
% of Float—
Days to Cover (Short Ratio)13.91
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +31.2%. Finnhub market metrics ↗
- Latest SEC filing is Form 8-K, filed 2026-09-25; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -0.4% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -33.4%. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ACHC
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $828.8M | — | $851.6M | $869.2M | $770.5M | — | $815.6M | $796.0M |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $4.1M | -$1.18B | $36.2M | $30.1M | $8.4M | $32.6M | $68.1M | $78.5M |
| EPS (diluted) | $0.05 | — | $0.40 | $0.33 | $0.09 | — | $0.74 | $0.85 |
| EPS (basic) | $0.05 | — | $0.40 | $0.33 | $0.09 | — | $0.74 | $0.86 |
| Net margin | $0 | — | $4 | $3 | $1 | — | $8 | $10 |
Balance sheet
| Line item | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $5.55B | $5.53B | $6.41B | $6.31B | $6.15B | $5.96B | $5.87B | $5.68B |
| Total liabilities | $3.38B | $3.39B | $3.12B | $3.08B | $2.97B | $2.77B | $2.72B | $2.61B |
| Stockholders' equity | $1.96B | $1.95B | $3.12B | $3.08B | $3.04B | $3.07B | $3.03B | $2.95B |
| Total current assets | $837.2M | $814.1M | $748.0M | $691.6M | $639.0M | $577.5M | $652.1M | $645.2M |
| Total current liabilities | $489.4M | $525.2M | $517.9M | $523.7M | $473.4M | $577.9M | $609.5M | $546.5M |
| Cash & equivalents | $158.5M | $133.2M | $118.7M | $131.4M | $91.2M | $76.3M | $82.1M | $77.2M |
| Accounts receivable | $471.8M | $440.6M | $430.8M | $408.5M | $396.6M | $365.3M | $383.9M | $389.4M |
| Inventory | $5.9M | $5.7M | $6.2M | $5.8M | $5.7M | $5.7M | $5.5M | $6.0M |
| Other current assets | $207.0M | $240.3M | $198.4M | $151.6M | $151.1M | $135.8M | $186.0M | $178.7M |
| Property, plant & equipment | $3.11B | $3.11B | $3.09B | $3.06B | $2.96B | $2.85B | $2.68B | $2.50B |
| Goodwill | $1.30B | $1.30B | $2.29B | $2.28B | $2.28B | $2.26B | $2.26B | $2.26B |
| Intangible assets | $98.6M | $96.7M | $85.2M | $79.5M | $78.8M | $70.0M | $73.1M | $73.3M |
| Other non-current assets | $68.0M | $72.5M | $59.6M | $59.5M | $53.6M | $52.0M | $75.1M | $74.2M |
| Accounts payable | $142.2M | $150.4M | $179.9M | $219.8M | $204.0M | $232.7M | $201.4M | $159.5M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | $3.2M | $2.8M | $3.3M | $1.7M | $1.8M | $1.7M | $1.7M | $1.8M |
| Short-term debt | $32.5M | $28.4M | $24.4M | $20.3M | $16.2M | $76.8M | $71.7M | $66.6M |
| Other current liabilities | $18.4M | $14.3M | $17.0M | $19.1M | $13.1M | $6.0M | $9.4M | $12.8M |
| Long-term debt | $2.49B | $2.47B | $2.28B | $2.25B | $2.18B | $1.88B | $1.80B | $1.77B |
| Other non-current liabilities | $196.3M | $201.6M | $130.6M | $139.8M | $134.1M | $122.3M | $150.5M | $150.6M |
| Common stock & paid-in capital | $908.0K | $905.0K | $904.0K | $904.0K | $904.0K | $918.0K | $918.0K | $917.0K |
| Retained earnings | -$761.7M | -$765.8M | $411.7M | $375.4M | $348.5M | $387.3M | $354.7M | $286.6M |
| Accumulated other comprehensive income (loss) | — | — | — | — | — | — | — | — |
Cash flow
| Line item | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $61.5M | -$86.3M | $73.2M | $133.5M | $11.5M | $116.7M | $163.1M | $171.1M |
| Investing cash flow | -$60.2M | -$92.4M | -$129.8M | -$150.8M | -$183.2M | -$203.3M | -$193.1M | -$155.5M |
| Financing cash flow | $23.9M | $193.3M | $43.8M | $57.5M | $186.7M | $80.8M | $34.9M | -$15.8M |
| Free cash flow | -$15.0M | -$179.5M | -$63.0M | -$34.2M | -$163.2M | -$86.8M | -$27.1M | $16.9M |
| Capital expenditures | $76.6M | $93.2M | $136.2M | $167.7M | $174.6M | $203.5M | $190.2M | $154.2M |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $8.0M | $23.0M | $6.0M | $10.5M | $8.7M | $28.4M | $9.5M | $8.9M |
| Deferred income taxes | $10.3M | -$2.2M | $12.1M | -$3.1M | -$5.6M | $11.6M | $17.1M | $21.5M |
| Change in accounts receivable | $31.1M | $10.1M | $22.3M | $11.7M | $31.0M | -$18.6M | -$5.2M | $3.2M |
| Change in accounts payable | — | — | — | — | — | — | — | — |
| Other investing activities | $30.0K | -$55.0K | $44.0K | $45.0K | $56.0K | $44.0K | $2.0K | $2.0M |
| Share repurchases | — | $0 | $0 | $3.2M | $46.9M | — | — | — |
| Debt issued | — | $0 | $0 | $0 | $1.20B | $0 | $0 | $0 |
| Debt repaid | — | — | — | — | — | — | — | — |
| Other financing activities | -$26.0K | -$23.0K | $3.0K | -$49.0K | -$21.0K | — | $361.0K | $8.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B |
| Operating income | — | — | — | — | — |
| Net income | -$1.10B | $255.6M | -$21.7M | $273.1M | $190.6M |
| EPS (diluted) | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 |
| EPS (basic) | $-12.16 | $2.79 | $-0.24 | $3.05 | $2.15 |
| Net margin | -$33 | $8 | -$1 | $10 | $8 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $5.53B | $5.96B | $5.36B | $4.99B | $4.77B |
| Total liabilities | $3.39B | $2.77B | $2.47B | $2.09B | $2.19B |
| Stockholders' equity | $1.95B | $3.07B | $2.78B | $2.81B | $2.52B |
| Total current assets | $814.1M | $577.5M | $596.0M | $506.1M | $495.0M |
| Total current liabilities | $525.2M | $577.9M | $885.8M | $388.3M | $404.9M |
| Cash & equivalents | $133.2M | $76.3M | $100.1M | $97.6M | $133.8M |
| Accounts receivable | $440.6M | $365.3M | $361.5M | $322.4M | $281.3M |
| Inventory | $5.7M | $5.7M | $5.3M | $5.1M | $4.8M |
| Other current assets | $240.3M | $135.8M | $134.5M | $86.0M | $79.9M |
| Property, plant & equipment | $3.11B | $2.85B | $2.27B | $1.95B | $1.77B |
| Goodwill | $1.30B | $2.26B | $2.23B | $2.22B | $2.20B |
| Intangible assets | $96.7M | $70.0M | $73.3M | $76.0M | $70.1M |
| Other non-current assets | $72.5M | $52.0M | $72.6M | $92.7M | $95.0M |
| Accounts payable | $150.4M | $232.7M | $156.1M | $104.7M | $98.6M |
| Accrued liabilities | — | — | — | — | — |
| Deferred revenue (current) | $2.8M | $1.7M | $2.2M | $6.7M | $30.4M |
| Short-term debt | $28.4M | $76.8M | $29.2M | $21.2M | $18.6M |
| Other current liabilities | $17.3M | $6.0M | $7.8M | $13.5M | $10.1M |
| Long-term debt | $2.47B | $1.88B | $1.34B | $1.36B | $1.48B |
| Other non-current liabilities | $201.6M | $122.3M | $140.1M | $125.0M | $110.5M |
| Common stock & paid-in capital | $905.0K | $918.0K | $913.0K | $899.0K | $890.0K |
| Retained earnings | -$765.8M | $387.3M | $131.7M | $153.4M | -$119.8M |
| Accumulated other comprehensive income (loss) | — | — | — | — | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $131.9M | $129.7M | $462.3M | $380.6M | $374.5M |
| Investing cash flow | -$556.2M | -$736.5M | -$397.2M | -$305.8M | $1.01B |
| Financing cash flow | $481.3M | $583.0M | -$62.7M | -$110.9M | -$1.64B |
| Free cash flow | -$439.9M | -$560.7M | $38.2M | $84.4M | $129.7M |
| Capital expenditures | $571.8M | $690.4M | $424.1M | $296.1M | $244.8M |
| Depreciation & amortization | — | — | — | — | — |
| Share-based compensation | $31.7M | $37.1M | $32.3M | $29.6M | $37.5M |
| Deferred income taxes | $1.1M | $67.7M | -$94.0M | $16.5M | $11.8M |
| Change in accounts receivable | $75.0M | $2.3M | $39.0M | $42.0M | -$2.4M |
| Other investing activities | $90.0K | $3.0M | $2.2M | $7.2M | $1.4M |
| Share repurchases | $50.0M | — | — | — | — |
| Debt issued | $1.20B | $350.0M | — | — | $425.0M |
| Debt repaid | — | — | — | — | — |
| Other financing activities | -$90.0K | — | $37.0K | $52.0K | -$6.9M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ACHC as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-06-26 to 2026-07-26
Recent transactions
- Most recent: Farley Brian (EVP, CLAO and Secretary) — Tax withholding of 1,770 shares on 2026-07-26.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Farley Brian | EVP, CLAO and Secretary | Tax withholding | 2026-07-26 | 1,770 |
| Fucci Michael | Reporting person | Grant / award | 2026-05-06 | 6,331 |
| KELLY RALPH DAVID | Reporting person | Grant / award | 2026-05-06 | 6,331 |
| Gregg Vicky B | Reporting person | Grant / award | 2026-05-06 | 6,331 |
| Bernhard Jason | Reporting person | Grant / award | 2026-05-06 | 6,331 |
| GRIECO WILLIAM | Reporting person | Grant / award | 2026-05-06 | 6,331 |
| Cancelmi Daniel J | Reporting person | Grant / award | 2026-05-06 | 6,331 |
| Harris Patrice A | Reporting person | Grant / award | 2026-05-06 | 6,331 |
| WAUD REEVE B | Reporting person | Grant / award | 2026-05-06 | 6,331 |
| Bissell E. Perot | Reporting person | Grant / award | 2026-05-06 | 6,331 |
| YOUNG TODD S. | Chief Financial Officer | Grant / award | 2026-04-10 | 58,799 |
| Khan Nasser | Chief Operating Officer | Tax withholding | 2025-09-30 | 973 |
| Dixon Heather Brianne | Chief Financial Officer | Tax withholding | 2025-07-25 | 2,410 |
| HUNTER CHRISTOPHER H. | Chief Executive Officer | Tax withholding | 2025-06-26 | 5,464 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-26 | Farley Brian | EVP, CLAO and Secretary | Tax withholding | 1,770 | $34.51 |
| 2026-06-26 | Farley Brian | EVP, CLAO and Secretary | Tax withholding | 1,370 | $26.24 |
| 2026-05-06 | Fucci Michael | Reporting person | Grant / award | 6,331 | $0.00 |
| 2026-05-06 | KELLY RALPH DAVID | Reporting person | Grant / award | 6,331 | $0.00 |
| 2026-05-06 | Gregg Vicky B | Reporting person | Grant / award | 6,331 | $0.00 |
| 2026-05-06 | Bernhard Jason | Reporting person | Grant / award | 6,331 | $0.00 |
| 2026-05-06 | Bernhard Jason | Reporting person | Grant / award | 5,124 | $0.00 |
| 2026-05-06 | GRIECO WILLIAM | Reporting person | Grant / award | 6,331 | $0.00 |
| 2026-05-06 | Cancelmi Daniel J | Reporting person | Grant / award | 6,331 | $0.00 |
| 2026-05-06 | Harris Patrice A | Reporting person | Grant / award | 6,331 | $0.00 |
| 2026-05-06 | WAUD REEVE B | Reporting person | Grant / award | 6,331 | $0.00 |
| 2026-05-06 | WAUD REEVE B | Reporting person | Grant / award | 9,576 | $0.00 |
| 2026-05-06 | Bissell E. Perot | Reporting person | Grant / award | 6,331 | $0.00 |
| 2026-05-06 | Bissell E. Perot | Reporting person | Grant / award | 5,500 | $0.00 |
| 2026-05-05 | Farley Brian | EVP, CLAO and Secretary | Tax withholding | 5,063 | $27.69 |
| 2026-04-28 | Farley Brian | EVP, CLAO and Secretary | Grant / award | 37,510 | $0.00 |
| 2026-04-10 | YOUNG TODD S. | Chief Financial Officer | Grant / award | 58,799 | $0.00 |
| 2026-04-10 | Farley Brian | EVP, GC and Secretary | Grant / award | 37,510 | $0.00 |
| 2026-03-12 | Cancelmi Daniel J | Reporting person | Grant / award | 6,625 | $0.00 |
| 2026-02-27 | Farley Brian | EVP, GC and Secretary | Tax withholding | 1,915 | $22.29 |
| 2025-10-27 | YOUNG TODD S. | Chief Financial Officer | Grant / award | 48,445 | $0.00 |
| 2025-09-30 | Khan Nasser | Chief Operating Officer | Tax withholding | 973 | $24.54 |
| 2025-07-26 | Farley Brian | EVP, GC and Secretary | Tax withholding | 1,095 | $22.26 |
| 2025-07-25 | Dixon Heather Brianne | Chief Financial Officer | Tax withholding | 2,410 | $21.74 |
| 2025-06-26 | HUNTER CHRISTOPHER H. | Chief Executive Officer | Tax withholding | 5,464 | $20.94 |
| 2025-06-26 | Dixon Heather Brianne | Chief Financial Officer | Tax withholding | 1,508 | $20.94 |
| 2025-06-26 | Farley Brian | EVP, GC and Secretary | Tax withholding | 847 | $20.94 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 02:08 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-25 | 8-K | 2026-09-25 | View on SEC.gov → |
| 2026-07-28 | 8-K | 2026-07-28 | View on SEC.gov → |
| 2026-07-28 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-27 | 4 | 2026-07-26 | View on SEC.gov → |
| 2026-06-26 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-05-18 | 8-K | 2026-05-18 | View on SEC.gov → |
| 2026-05-08 | 4 | 2026-05-06 | View on SEC.gov → |
| 2026-05-08 | 4 | 2026-05-06 | View on SEC.gov → |
| 2026-05-08 | 4 | 2026-05-06 | View on SEC.gov → |
| 2026-05-08 | 4 | 2026-05-06 | View on SEC.gov → |
| 2026-05-08 | 4 | 2026-05-06 | View on SEC.gov → |
| 2026-05-08 | 4 | 2026-05-06 | View on SEC.gov → |
Recent news
Headlines about ACHC (Acadia Healthcare Company, Inc.). Links open the publisher — we don’t host full articles.
-
DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line
Yahoo Finance · 2026-10-21 -
Labcorp Prepares to Report Q3 Earnings: What's in the Cards?
Yahoo Finance · 2026-10-21 -
Is It Too Late to Buy Acadia Healthcare Co Inc (ACHC) After 4.1% Rally? GF Value Says Undervalued
GuruFocus · 2026-10-21 -
How Acadia Healthcare Company Inc. (ACHC) Affects Rotational Strategy Timing
Stock Traders Daily · 2026-10-20 -
Universal Health: Bears Have Taken It Too Far - 134% Upside
SeekingAlpha · 2026-10-20 -
Acadia Healthcare Company (ACHC) Could Be 11% Undervalued On Its Growth Narrative
Yahoo · 2026-10-17 -
Acadia Healthcare (ACHC) Stock May Be Below Fair Value On Sales
Yahoo · 2026-10-17 -
Can Molina Healthcare Overcome Lower Premiums and Higher MCR in Q3?
Yahoo · 2026-10-16
No headlines in this category right now — try “All”.